Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHENE: Neuroaid II in Alzheimer's Disease
NCT03038035Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Dec 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mlc901 in Alzheimer's disease (AD), sponsored by National University Hospital. Status: unknown.
02
Drugs
mlc901
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03038035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038035.